LuminUltra expands with acquisition of Source Molecular Corporation


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ LuminUltra expands with acquisition of Source Molecular Corporation
LuminUltra increases testing capacity including the range of COVID-19 offerings with the acquisition

Biotechnology front-runner LuminUltra announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of use cases. Customers around the world can now choose to analyze samples remotely via mail-in service to Source Molecular, or rapidly onsite using LuminUltra's gold standard GeneCount qPCR testing kits.

LuminUltra is a global leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring. Founded in 1995, it has been on a deliberate and accelerated growth trajectory over recent years. Through strategic acquisitions of multiple companies as well as a partnership with private equity firm XPV Water Partners, LuminUltra has proactively grown its portfolio to add capacity and testing options for customers to access their testing solution of choice – all from a single, dependable source.

"Our main priority at LuminUltra continues to be to deliver reliable solutions and options to help customers improve their safety and testing protocols," says LuminUltra Chairman and CEO Pat Whalen. "Source Molecular and LuminUltra have benefited from a partnership over recent months to deliver essential COVID-19 environmental surveillance monitoring, including Source Molecular's industry-leading, lab-based pathogen testing capabilities. This natural next step for LuminUltra and Source Molecular will enable us to further meet our shared objective to deliver greater access to a full suite of industry-leading solutions, increasing testing capacity worldwide and directly helping to combat the COVID-19 pandemic."

"This type of access to reliable molecular testing solutions is crucial both during the pandemic, as well as beyond as the public looks for greater understanding of pathogens that may be present or forming in their systems," adds Whalen.

"Source Molecular is thrilled to join the LuminUltra team," says Source Molecular director Kirk Shryock. "Our team is passionate about molecular and pathogenic source tracking and it is exciting to bring this expertise to a company with a strong management team and a vision for bringing this unique capability to a broader market."

This combination of expertise and capacity enables further worldwide expansion with innovative and flexible solutions while ensuring a seamless transition and continuity for existing loyal customers. Through the integration of the two companies, LuminUltra and Source Molecular will retain their existing brands.

Tags : #LuminUltra #SourceMolecularCorporation #CovidTestingCapacity #QpcrTestingKit #LatestPharmaNewsDec2

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026